GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ChitogenX Inc (XCNQ:CHGX) » Definitions » Other Income (Expense)

ChitogenX (XCNQ:CHGX) Other Income (Expense) : C$2.00 Mil (TTM As of Jan. 2024)


View and export this data going back to 2017. Start your Free Trial

What is ChitogenX Other Income (Expense)?

ChitogenX's other income expense for the ChitogenX's pretax income for the three months ended in Jan. 2024 was C$0.44 Mil. Its other income expense for the trailing twelve months (TTM) ended in Jan. 2024 was C$2.00 Mil.

ChitogenX Other Income (Expense) Historical Data

The historical data trend for ChitogenX's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ChitogenX Other Income (Expense) Chart

ChitogenX Annual Data
Trend Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only 0.05 -0.01 -0.42 -0.12 2.00

ChitogenX Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.68 1.47 0.34 -0.25 0.44

ChitogenX Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$2.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ChitogenX  (XCNQ:CHGX) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

ChitogenX (XCNQ:CHGX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ChitogenX Inc (XCNQ:CHGX) » Definitions » Other Income (Expense)
Comparable Companies
XCNQ:BETR XCNQ:DRUG TSXV:RKV TSXV:XRTX XCNQ:TRYP TSXV:HEM TSXV:RP XCNQ:MESC TSXV:IOT TSX:APLI OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
CHNXF:USA
Address
16667 Hymus Boulevard, Kirkland, Montreal, QC, CAN, H9H 4R9
Website
https://www.chitogenx.com
ChitogenX Inc is a clinical-stage biotech company. It operates in one segment, which is the development of novel therapeutic soft tissue repair technologies.

ChitogenX (XCNQ:CHGX) Headlines

From GuruFocus

IMPACTfolio, LLC Buys 3, Sells 2 in 2nd Quarter

By GuruFocus Research GuruFocus Editor • 07-06-2022

Top 5 3rd Quarter Trades of Colorado Capital Management, Inc.

By GuruFocus Research GuruFocus Editor • 10-19-2022

Top 5 4th Quarter Trades of Colorado Capital Management, Inc.

By GuruFocus Research GuruFocus Editor • 01-18-2023

AXS Investments Acquires Industry's First-Ever Certified Carbon-Neutral ETF (CHGX) Expanding Its ETF and ESG Lineup

By PRNewswire PRNewswire • 03-21-2022